.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Johnson and Johnson
Argus Health
Express Scripts
US Army
Accenture
Cipla
Mallinckrodt
Queensland Health
Dow

Generated: July 25, 2017

DrugPatentWatch Database Preview

Pyridostigmine bromide - Generic Drug Details

« Back to Dashboard

What are the generic sources for pyridostigmine bromide and what is the scope of pyridostigmine bromide patent protection?

Pyridostigmine bromide
is the generic ingredient in three branded drugs marketed by Impax Labs, Ani Pharms Inc, Us Army, Valeant Pharms Llc, Valeant Pharm Intl, Alvogen Malta, Zydus Pharms Usa Inc, Impax Labs Inc, Solvay, Valeant Pharms, and Sandoz Inc, and is included in thirteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for pyridostigmine bromide. Eleven suppliers are listed for this compound.

Summary for Generic Name: pyridostigmine bromide

Tradenames:3
Patents:1
Applicants:11
NDAs:13
Drug Master File Entries: see list11
Suppliers / Packagers: see list11
Bulk Api Vendors: see list64
Clinical Trials: see list296
Patent Applications: see list813
Therapeutic Class:Antimyasthenic Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:pyridostigmine bromide at DailyMed

Pharmacology for Ingredient: pyridostigmine bromide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc
PYRIDOSTIGMINE BROMIDE
pyridostigmine bromide
TABLET;ORAL040512-002Jul 20, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe
Impax Labs Inc
PYRIDOSTIGMINE BROMIDE
pyridostigmine bromide
TABLET;ORAL040457-001Dec 26, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
Valeant Pharm Intl
MESTINON
pyridostigmine bromide
INJECTABLE;INJECTION009830-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Impax Labs
PYRIDOSTIGMINE BROMIDE
pyridostigmine bromide
TABLET;ORAL040502-001Apr 24, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe
Impax Labs Inc
PYRIDOSTIGMINE BROMIDE
pyridostigmine bromide
TABLET, EXTENDED RELEASE;ORAL203184-001Sep 15, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
US Army
Chubb
Fuji
Farmers Insurance
US Department of Justice
Argus Health
Baxter
Johnson and Johnson
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot